Francois Delhommeau

1970 -

scuola frequentata: Sorbonne Universités

occupazione: ricercatore

Serie

There is nothing here

Crea una nuova serie

Opere

There is nothing here

Crea un nuovo lavoro

Articoli 42

Data

Titolo

Autori

2022-02-03

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytes

Dorothée Selimoglu-Buet, Raphael A. Itzykson, Thierry Roger, Orianne Wagner-Ballon, Maria E. Figueroa, Olivier Bernard, William Vainchenker, Eric Solary, Nathalie Droin, Bouchra Badaoui, Francois Delhommeau
2020-06-24

Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy

Marco Cerrano, Matthieu Duchmann, Rathana Kim, Raphael A. Itzykson, Pierre Fenaux, Lionel Adès, Emmanuel Raffoux, Nicolas Boissel, Karine Celli-Lebras, Samuel Quentin, Emmanuelle Clappier, Francois Delhommeau, Marie Passet, Anna Raimbault, Marie Sébert
2018-01-01

TP53 mutations: the dawn of Shwachman clones.

Jean Donadieu, Francois Delhommeau
2018-12-03

Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease

Francois Delhommeau
2017-03-16

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia

Ludovic Suner, Francois Delhommeau
2017-04-17

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.

Francois Delhommeau, Clément Larrue, Nizar Serhan, Laetitia Linares, Yves Collette, Tony Lionel Palama, Barbara Garmy-Susini, Jean-Charles Portais, François Vergez
2016-03-07

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia

Francois Delhommeau, Laurent Le Cam, Laetitia Linares, Jean-Charles Portais, François Vergez
2016-08-18

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia

Virginie Joulin, Fawzia Louache, Francois Delhommeau
2016-08-24

Reed Sternberg cell/lymphocyte rosettes in a bone marrow aspirate leading to the diagnosis of Hodgkin lymphoma

Ludovic Suner, Francois Delhommeau
2016-03-01

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation

Francois Delhommeau, Ludovic Suner
2014-06-27

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines

Pauline Nauroy, Francois Delhommeau
2014-08-01

TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells

Kristian Helin, Nathalie Droin, Thomas Mercher, Francois Delhommeau, Olivier Bernard, Eric Solary, William Vainchenker, Isabelle Plo, Nathalie Auger, Gaëlle Lenglet, Caroline Marty, Najet Debili
2014-06-04

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution

Francois Delhommeau, Myriam Labopin
2013-01-14

Clonal architecture of chronic myelomonocytic leukemias

Raphael A. Itzykson, Olivier Kosmider, Claude Preudhomme, Francois Delhommeau, Olivier Bernard, Michaela Fontenay, William Vainchenker, Nathalie Droin, Eric Solary, Uwe Platzbecker, Pierre Fenaux, Margot Morabito, Lionel Adès, Aline Renneville, Guillaume Meurice, Cédric Oréar
2012-11-16

Applying ecological and evolutionary theory to cancer: a long and winding road

Eric Solary, Vjekoslav Dulic, Jean Clairambault, Daniel Fisher, Benjamin Roche, Dorothée Missé, Christoph Grunau, Raphael A. Itzykson, Benoit Perthame, Urszula Hibner, Guillaume Mitta, Frédéric Thomas, Céline Cosseau, William Vainchenker, Liliana Krasinska, Corinne Quittau-Prevostel, Hélène Trauchessec, Emmanuel Vignal, Michael E. Hochberg, Annabelle Ballesta, Francois Delhommeau
2012-03-01

Role of TET2 mutations in myeloproliferative neoplasms

Francois Delhommeau
2011-07-12

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

William Vainchenker, Eric Solary, Florence Nguyen-Khac, Cyril Quivoron, Lucile Couronné, Thomas Mercher, Francois Delhommeau, Marc-Henri Stern, Isabelle Plo, Paule Opolon, Orianne Wagner-Ballon, Cécile K Lopez
2011-01-17

The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues

Steffen Koschmieder, Francois Delhommeau, Anthony R Green, Tessa Holyoake, Robert Peter Gale, Steffen Koschmieder
2011-06-07

New mutations and pathogenesis of myeloproliferative neoplasms

William Vainchenker, Francois Delhommeau, Stefan N. Constantinescu, Olivier Bernard
2011-11-07

The cell cycle regulator CDC25A is a target for JAK2V617F oncogene

Jean-Luc Villeval, Francois Delhommeau, Bernard Ducommun, Elizabeth O. Hexner
2011-08

TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

Paule Opolon, Francois Delhommeau, Thomas Mercher, Marc-Henri Stern, Eric Solary, William Vainchenker
2010-03-01

Primary plasma cell leukemia mimicking an adult T-cell leukemia-lymphoma: a case report

Francois Delhommeau
2010-02-27

Molecular aspects of myeloproliferative neoplasms

Francois Delhommeau
2009-12-11

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm

Mark A. Dawson, Francois Delhommeau, William Vainchenker, Anthony R Green
2009-10-01

[Mutations in TET2 in myeloid cancers]

Olivier Bernard, Francois Delhommeau, Michaela Fontenay, William Vainchenker
2009-06-29

Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms

Francois Delhommeau, Isabelle Plo, Christine Chomienne, Olivier Bernard, William Vainchenker, Dominique Bordessoule, Cécile Saint-Martin, Gwendoline Leroy, Francoise Isnard, Albert Najman, Christine Bellanné-Chantelot
2008-07-08

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Frédéric Mazurier, Ronan Chaligné, Francois Delhommeau, William Vainchenker
2007-04-06

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers

Annelise Bennaceur Griscelli, Francois Delhommeau
2007-03-27

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

William Vainchenker, Francois Delhommeau
2006-09-05

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis

Francois Delhommeau, Isabelle Godin, William Vainchenker
2006-02-01

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis

Francois Delhommeau, William Vainchenker
2006-08-10

Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators

Francois Delhommeau, William Vainchenker, Daniel Birnbaum

Human - wd:Q53876560

Benvenuto su Inventaire

la biblioteca dei tuoi amici e della tua comunità

ulteriori informazioni